387322000: Dihydrocodeine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Opioid receptor agonist\Phenanthrene derivative (substance)\Dihydrocodeine (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Opioid receptor agonist\Phenanthrene derivative (substance)\Dihydrocodeine (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Analgesic (substance)\Phenanthrene derivative (substance)\Dihydrocodeine (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Psychoactive substance (substance)\Central depressant\Phenanthrene derivative (substance)\Dihydrocodeine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Hydrocarbon\Aromatic hydrocarbon (substance)\Phenanthrene\Phenanthrene derivative (substance)\Dihydrocodeine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461500016 Dihydrocodeine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481421012 Dihydrocodeine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4499251000005111 Dihydrocodein da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dihydrocodeine (substance)	Is a	Opiatagonist/-antagonist	false	Inferred relationship	Some
Dihydrocodeine (substance)	Is a	Drug allergen	false	Inferred relationship	Some
Dihydrocodeine (substance)	Is a	Phenanthrene derivative (substance)	true	Inferred relationship	Some
Dihydrocodeine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Opioid receptor agonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dihydrocodeine measurement	Component	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Poisoning by dihydrocodeine	Causative agent	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Intentional dihydrocodeine overdose (disorder)	Causative agent	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Accidental poisoning by dihydrocodeine	Causative agent	False	Dihydrocodeine (substance)	Inferred relationship	Some
Intentional poisoning by dihydrocodeine	Causative agent	False	Dihydrocodeine (substance)	Inferred relationship	Some
forgiftning med dihydrocodein, uvist med hvilken hensigt	Causative agent	False	Dihydrocodeine (substance)	Inferred relationship	Some	1
Dihydrocodeine adverse reaction	Causative agent	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Allergy to dihydrocodeine (finding)	Causative agent	False	Dihydrocodeine (substance)	Inferred relationship	Some
Overdose of dihydrocodeine	Causative agent	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Accidental overdose by dihydrocodeine	Causative agent	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
overdosis af dihydrocodein, uvist med hvilken hensigt	Causative agent	False	Dihydrocodeine (substance)	Inferred relationship	Some	1
Urine dihydrocodeine measurement (procedure)	Component	False	Dihydrocodeine (substance)	Inferred relationship	Some	2
dihydrocodeintartrat 30 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some
dihydrocodeintartrat 10 mg/5 ml oral opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some
dihydrocodeintartrat 50 mg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some
dihydrocodeintartrat 60 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some
dihydrocodeintartrat 90 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some
dihydrocodeintartrat 120 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some
dihydrocodeintartrat 40 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some
Product containing dihydrocodeine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some
acetylsalicylsyre + caffein + dihydrocodeinbitartrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some
paracetamol + caffein + dihydrocodeinbitartrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some
Dihydrocodeinbitartrat	Is a	False	Dihydrocodeine (substance)	Inferred relationship	Some
Dihydrocodeine tartrate	Is a	False	Dihydrocodeine (substance)	Inferred relationship	Some
Accidental poisoning by dihydrocodeine	Causative agent	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Intentional poisoning by dihydrocodeine	Causative agent	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Urine dihydrocodeine screening test	Component	False	Dihydrocodeine (substance)	Inferred relationship	Some	2
Quantitative measurement of mass concentration of dihydrocodeine in saliva specimen (procedure)	Component	False	Dihydrocodeine (substance)	Inferred relationship	Some	2
Allergy to dihydrocodeine (finding)	Causative agent	False	Dihydrocodeine (substance)	Inferred relationship	Some	2
dihydrocodeintartrat 30 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some	1
dihydrocodeintartrat 30 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Dihydrocodeine (substance)	Inferred relationship	Some	1
dihydrocodeintartrat 40 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dihydrocodeine (substance)	Inferred relationship	Some	1
dihydrocodeintartrat 40 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Dihydrocodeine (substance)	Inferred relationship	Some	1
Dihydrocodeine tartrate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Dihydrocodeine (substance)	Inferred relationship	Some
Product containing dihydrocodeine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
dihydrocodeintartrat 40 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Dihydrocodeine (substance)	Inferred relationship	Some	1
dihydrocodeintartrat 30 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Dihydrocodeine (substance)	Inferred relationship	Some	1
Product containing aspirin and caffeine and dihydrocodeine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	2
Product containing aspirin and caffeine and dihydrocodeine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	2
Product containing caffeine and dihydrocodeine and paracetamol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	2
Product containing caffeine and dihydrocodeine and paracetamol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	2
Product containing dihydrocodeine and paracetamol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Dihydrocodeine-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Product containing dihydrocodeine and paracetamol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Caffeine and dihydrocodeine and paracetamol only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	2
Aspirin and caffeine and dihydrocodeine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	2
Product containing only dihydrocodeine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Dihydrocodeine and paracetamol only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Product containing only caffeine and dihydrocodeine and paracetamol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	2
Product containing only dihydrocodeine and paracetamol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Product containing only dihydrocodeine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Product containing only dihydrocodeine in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Aspirin and caffeine and dihydrocodeine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Dihydrocodeine (substance)	Inferred relationship	Some	2
Allergy to dihydrocodeine (finding)	Causative agent	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Quantitative measurement of mass concentration of dihydrocodeine in saliva specimen (procedure)	Component	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Urine dihydrocodeine measurement (procedure)	Component	True	Dihydrocodeine (substance)	Inferred relationship	Some	1
Urine dihydrocodeine screening test	Component	True	Dihydrocodeine (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461500016	Dihydrocodeine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481421012	Dihydrocodeine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4499251000005111	Dihydrocodein	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)